-
1
-
-
0000593691
-
Malignant tumours of the breast
-
DeVita VT, Hellman S, Rosenberg SA (eds). Lippincott-Raven, New York
-
Harris J, Morrow M, Norton L: Malignant tumours of the breast. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: Principals and Practice of Oncology, 5th Edition. Lippincott-Raven, New York, 1997, pp 1557-1616
-
(1997)
Cancer: Principals and Practice of Oncology, 5th Edition
, pp. 1557-1616
-
-
Harris, J.1
Morrow, M.2
Norton, L.3
-
2
-
-
0029903615
-
Recent trends in U.S. breast cancer incidence, survival, and mortality rates
-
Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, Edwards BK: Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 88:1571-1579, 1996
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1571-1579
-
-
Chu, K.C.1
Tarone, R.E.2
Kessler, L.G.3
Ries, L.A.4
Hankey, B.F.5
Miller, B.A.6
Edwards, B.K.7
-
3
-
-
0028091136
-
Axillary lymph node dissection for Tla breast carcinoma. Is it indicated?
-
Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P: Axillary lymph node dissection for Tla breast carcinoma. Is it indicated? Cancer 73:664-667, 1994
-
(1994)
Cancer
, vol.73
, pp. 664-667
-
-
Silverstein, M.J.1
Gierson, E.D.2
Waisman, J.R.3
Senofsky, G.M.4
Colburn, W.J.5
Gamagami, P.6
-
4
-
-
0027683226
-
Structural biochemistry and activation of matrix metalloproteinases
-
Kleiner DJ, Stetler-Stevenson WG: Structural biochemistry and activation of matrix metalloproteinases. Curr Opin Cell Biol 5:891-897, 1993
-
(1993)
Curr Opin Cell Biol
, vol.5
, pp. 891-897
-
-
Kleiner, D.J.1
Stetler-Stevenson, W.G.2
-
5
-
-
0030717692
-
Tissue inhibitors of metalloproteinases - Structure, regulation and biological functions
-
Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP: Tissue inhibitors of metalloproteinases - structure, regulation and biological functions. Eur J Cell Biol 74:111-122, 1997
-
(1997)
Eur J Cell Biol
, vol.74
, pp. 111-122
-
-
Gomez, D.E.1
Alonso, D.F.2
Yoshiji, H.3
Thorgeirsson, U.P.4
-
6
-
-
0022499616
-
Human fibroblast collagenase: Glycosylation and tissue-specific levels of enzyme synthesis
-
Wilhelm SC, Eisen AZ, Teter M, Clark SD, Kronberger A, Goldberg G: Human fibroblast collagenase: glycosylation and tissue-specific levels of enzyme synthesis. Proc Nad Acad Sci USA 83:3756-3760, 1986
-
(1986)
Proc Nad Acad Sci USA
, vol.83
, pp. 3756-3760
-
-
Wilhelm, S.C.1
Eisen, A.Z.2
Teter, M.3
Clark, S.D.4
Kronberger, A.5
Goldberg, G.6
-
7
-
-
0025874373
-
Human 92- and 72-kilodalton type IV collagenases are elastases
-
Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG: Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem 266:7870-7875, 1991
-
(1991)
J Biol Chem
, vol.266
, pp. 7870-7875
-
-
Senior, R.M.1
Griffin, G.L.2
Fliszar, C.J.3
Shapiro, S.D.4
Goldberg, G.I.5
Welgus, H.G.6
-
8
-
-
0027515289
-
Cloning and characterisation of a unique elastolytic metalloproteinase produced by human alveolar macrophages
-
Shapiro SD, Kobayashi DK, Ley TJ: Cloning and characterisation of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 268:23824-23829, 1993
-
(1993)
J Biol Chem
, vol.268
, pp. 23824-23829
-
-
Shapiro, S.D.1
Kobayashi, D.K.2
Ley, T.J.3
-
9
-
-
0028291737
-
A matrix metalloproteinase expressed on the surface of invasive tumour cells
-
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61-65, 1994
-
(1994)
Nature
, vol.370
, pp. 61-65
-
-
Sato, H.1
Takino, T.2
Okada, Y.3
Cao, J.4
Shinagawa, A.5
Yamamoto, E.6
Seiki, M.7
-
10
-
-
0025641098
-
A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
-
Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704, 1990
-
(1990)
Nature
, vol.348
, pp. 699-704
-
-
Basset, P.1
Bellocq, J.P.2
Wolf, C.3
Stoll, I.4
Hutin, P.5
Limacher, J.M.6
Podhajcer, O.L.7
Chenard, M.P.8
Rio, M.C.9
Chambon, P.10
-
11
-
-
0028116127
-
Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3
-
Pei D, Majmudar G, Weiss SJ: Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem 269: 25849-25855, 1994
-
(1994)
J Biol Chem
, vol.269
, pp. 25849-25855
-
-
Pei, D.1
Majmudar, G.2
Weiss, S.J.3
-
12
-
-
0028485654
-
Processing of tumour necrosis factor-α precursor by metalloproteinases
-
Gearing AJH, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, Woolley K: Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370:555-557, 1994
-
(1994)
Nature
, vol.370
, pp. 555-557
-
-
Gearing, A.J.H.1
Beckett, P.2
Christodoulou, M.3
Churchill, M.4
Clements, J.5
Davidson, A.H.6
Drummond, A.H.7
Galloway, W.A.8
Gilbert, R.9
Gordon, J.L.10
Leber, T.M.11
Mangan, M.12
Miller, K.13
Nayee, P.14
Owen, K.15
Patel, S.16
Thomas, W.17
Wells, G.18
Wood, L.M.19
Woolley, K.20
more..
-
13
-
-
0030581634
-
Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour-necrosis factor-α fusion protein
-
Chandler S, Cossins J, Lury J, Wells G: Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour-necrosis factor-α fusion protein. Biochem Biophys Res Conunun 228:421-429, 1996
-
(1996)
Biochem Biophys Res Conunun
, vol.228
, pp. 421-429
-
-
Chandler, S.1
Cossins, J.2
Lury, J.3
Wells, G.4
-
14
-
-
8044257704
-
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells
-
Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL: A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729-733, 1997
-
(1997)
Nature
, vol.385
, pp. 729-733
-
-
Black, R.A.1
Rauch, C.T.2
Kozlosky, C.J.3
Peschon, J.J.4
Slack, J.L.5
-
15
-
-
8044250278
-
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha
-
Moss ML, Jin SL, Milla ME, Burkhart W, Carter HL: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385:733-736, 1997
-
(1997)
Nature
, vol.385
, pp. 733-736
-
-
Moss, M.L.1
Jin, S.L.2
Milla, M.E.3
Burkhart, W.4
Carter, H.L.5
-
16
-
-
0002023426
-
Recent advances in matrix metalloproteinase inhibitor research
-
Beckett RP, Davidson AH, Drummond AH, Huxley P, Whittaker M: Recent advances in matrix metalloproteinase inhibitor research. Drug Dev Today 1:16-26, 1996
-
(1996)
Drug Dev Today
, vol.1
, pp. 16-26
-
-
Beckett, R.P.1
Davidson, A.H.2
Drummond, A.H.3
Huxley, P.4
Whittaker, M.5
-
17
-
-
0029586589
-
Matrix metalloproteinase inhibition: A review of anti-tumour activity
-
Brown PD, Giavazzi R: Matrix metalloproteinase inhibition: a review of anti-tumour activity. Ann Oncol 6:967-974, 1995
-
(1995)
Ann Oncol
, vol.6
, pp. 967-974
-
-
Brown, P.D.1
Giavazzi, R.2
-
18
-
-
0028838862
-
Structure determination and analysis of human neutrophil collagenase complexed with a hydoxamate inhibitor
-
Grams F, Crimmin M, Hinnes L, Huxley P, Pieper M, Tschesche H, Bode W: Structure determination and analysis of human neutrophil collagenase complexed with a hydoxamate inhibitor. Biochemistry 34:14012-14020, 1995
-
(1995)
Biochemistry
, vol.34
, pp. 14012-14020
-
-
Grams, F.1
Crimmin, M.2
Hinnes, L.3
Huxley, P.4
Pieper, M.5
Tschesche, H.6
Bode, W.7
-
19
-
-
0027996297
-
Potent and selective inhibitors of gelatinase A. 2 - Carboxylic acids and phosphonic acid derivatives
-
Morphy JR, Beeley NRA, Boyce BA: Potent and selective inhibitors of gelatinase A. 2. Carboxylic acids and phosphonic acid derivatives. Bioorg Med Chem Lett 4:2747-2752, 1994
-
(1994)
Bioorg Med Chem Lett
, vol.4
, pp. 2747-2752
-
-
Morphy, J.R.1
Beeley, N.R.A.2
Boyce, B.A.3
-
20
-
-
0030816454
-
Rodent pharmacokinetic and anti-tumor efficacy studies with a series of synthetic inhibitors of matrix metalloproteinases
-
Santos O, McDermott CD, Daniels RG, Appelt K: Rodent pharmacokinetic and anti-tumor efficacy studies with a series of synthetic inhibitors of matrix metalloproteinases. Clin Exp Met 15: 499-508, 1997
-
(1997)
Clin Exp Met
, vol.15
, pp. 499-508
-
-
Santos, O.1
McDermott, C.D.2
Daniels, R.G.3
Appelt, K.4
-
21
-
-
0001015980
-
A phase I study of the matrix metalloproteinase (MMP) inhibitor AG3340 given in single doses to healthy volunteers
-
Collier MA, Yuen GJ, Bansal SK, Kolis S, Chew TG, Appelt K, Clendeninn NJ: A phase I study of the matrix metalloproteinase (MMP) inhibitor AG3340 given in single doses to healthy volunteers. Proc Am Assoc Cancer Res 38:13, 1997
-
(1997)
Proc Am Assoc Cancer Res
, vol.38
, pp. 13
-
-
Collier, M.A.1
Yuen, G.J.2
Bansal, S.K.3
Kolis, S.4
Chew, T.G.5
Appelt, K.6
Clendeninn, N.J.7
-
22
-
-
8244221001
-
Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo
-
Lewis EJ, Bishop J, Bottomley KMK, Bradshaw D, Brewster M, Broadhurst MJ, Brown PA, Budd JM, Elliott L, Greenham AK, Johnson WH, Nixon JS, Rose F, Sutton B, Wilson K: Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo. Br J Pharmacol 121:540-546, 1997
-
(1997)
Br J Pharmacol
, vol.121
, pp. 540-546
-
-
Lewis, E.J.1
Bishop, J.2
Bottomley, K.M.K.3
Bradshaw, D.4
Brewster, M.5
Broadhurst, M.J.6
Brown, P.A.7
Budd, J.M.8
Elliott, L.9
Greenham, A.K.10
Johnson, W.H.11
Nixon, J.S.12
Rose, F.13
Sutton, B.14
Wilson, K.15
-
23
-
-
0002338012
-
The tolerability and pharmacokinetics of the cartilage protective agent (Ro32-3555) in healthy male volunteers
-
Wood ND, Aitken M, Harris S, Kitchener S, McClelland GR, Sharp S: The tolerability and pharmacokinetics of the cartilage protective agent (Ro32-3555) in healthy male volunteers. Br J Clin Pharm 42:676-677, 1996
-
(1996)
Br J Clin Pharm
, vol.42
, pp. 676-677
-
-
Wood, N.D.1
Aitken, M.2
Harris, S.3
Kitchener, S.4
McClelland, G.R.5
Sharp, S.6
-
24
-
-
0030475119
-
Recent advances in the field of matrix metalloproteinase inhibitors (patent update)
-
Beckett RP: Recent advances in the field of matrix metalloproteinase inhibitors (patent update). Exp Opin Ther Patents 6:1305-1315, 1996
-
(1996)
Exp Opin Ther Patents
, vol.6
, pp. 1305-1315
-
-
Beckett, R.P.1
-
25
-
-
0030949716
-
Gelastatins A and B, new inhibitors of gelatinase A from Westerdykella multispora F50733
-
Lee H-J, Chung M-C, Lee C-H, Yun B-S, Chun H-K, Kho Y-H: Gelastatins A and B, new inhibitors of gelatinase A from Westerdykella multispora F50733. J Antibiot 50:357-359, 1996
-
(1996)
J Antibiot
, vol.50
, pp. 357-359
-
-
Lee, H.-J.1
Chung, M.-C.2
Lee, C.-H.3
Yun, B.-S.4
Chun, H.-K.5
Kho, Y.-H.6
-
26
-
-
0027519832
-
Inhibition of metalloproteinase activity of rheumatoid arthritis synovial cells by a new inhibitor [BE16627B; L-N-(N-hydroxy-2-isobutylsuccinamoyl)-seryl-L-valine]
-
Naito K, Nakajima S, Kanbayashi N, Okuyama A, Goto M: Inhibition of metalloproteinase activity of rheumatoid arthritis synovial cells by a new inhibitor [BE16627B; L-N-(N-hydroxy-2-isobutylsuccinamoyl)-seryl-L-valine]. Agents Actions 39:182-186, 1993
-
(1993)
Agents Actions
, vol.39
, pp. 182-186
-
-
Naito, K.1
Nakajima, S.2
Kanbayashi, N.3
Okuyama, A.4
Goto, M.5
-
27
-
-
0023245356
-
A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity
-
Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS: A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dental Res 66:1310-1314, 1987
-
(1987)
J Dental Res
, vol.66
, pp. 1310-1314
-
-
Golub, L.M.1
McNamara, T.F.2
D'Angelo, G.3
Greenwald, R.A.4
Ramamurthy, N.S.5
-
28
-
-
0023919232
-
Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells
-
Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC, Miskin R: Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48:3307-3312, 1988
-
(1988)
Cancer Res
, vol.48
, pp. 3307-3312
-
-
Reich, R.1
Thompson, E.W.2
Iwamoto, Y.3
Martin, G.R.4
Deason, J.R.5
Fuller, G.C.6
Miskin, R.7
-
29
-
-
0028129059
-
Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor
-
Chirivi RS, Garofalo A, Crimmin MJ, Bawden LJ, Brown PD, Giavazzi RG: Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer 58:460-464, 1994
-
(1994)
Int J Cancer
, vol.58
, pp. 460-464
-
-
Chirivi, R.S.1
Garofalo, A.2
Crimmin, M.J.3
Bawden, L.J.4
Brown, P.D.5
Giavazzi, R.G.6
-
30
-
-
0027994031
-
Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumour growth and spread in a patient-like orthotopic model in nude mice
-
Wang X, Fu X, Brown PD, Crimmin MJ, Hoffman RM: Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumour growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 54:4726-4728, 1994
-
(1994)
Cancer Res
, vol.54
, pp. 4726-4728
-
-
Wang, X.1
Fu, X.2
Brown, P.D.3
Crimmin, M.J.4
Hoffman, R.M.5
-
31
-
-
8244260609
-
Conversion of a highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor
-
An Z, Wang X, Willmott N, Chander SK, Tickle S, Docherty AJP, Mountain A, Millican AT, Morphy R, Porter JR, Epemolu RO, Kubota T, Moossa AR, Hoffman RM: Conversion of a highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor. Clin Exp Met 15: 184-195, 1997
-
(1997)
Clin Exp Met
, vol.15
, pp. 184-195
-
-
An, Z.1
Wang, X.2
Willmott, N.3
Chander, S.K.4
Tickle, S.5
Docherty, A.J.P.6
Mountain, A.7
Millican, A.T.8
Morphy, R.9
Porter, J.R.10
Epemolu, R.O.11
Kubota, T.12
Moossa, A.R.13
Hoffman, R.M.14
-
32
-
-
0025351278
-
Identification of an inhibitor of neovascularization from cartilage
-
Moses MA, Sudhalter J, Langer R: Identification of an inhibitor of neovascularization from cartilage. Science 248:1408-1410, 1990
-
(1990)
Science
, vol.248
, pp. 1408-1410
-
-
Moses, M.A.1
Sudhalter, J.2
Langer, R.3
-
33
-
-
0028939303
-
Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases
-
Taraboletti G, Garofalo A, Belotti D, Drudis T, Borsotti P, Scanziani E, Brown P, Giavazzi R: Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J Natl Cancer Inst 87:293-298, 1995
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 293-298
-
-
Taraboletti, G.1
Garofalo, A.2
Belotti, D.3
Drudis, T.4
Borsotti, P.5
Scanziani, E.6
Brown, P.7
Giavazzi, R.8
-
34
-
-
0029934985
-
Control of lymphatic and hematogenous metastases of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94)
-
Eccles SA, Box GM, Court WJ, Bone EA, Thomas W, Brown PD: Control of lymphatic and hematogenous metastases of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res 56:2815-2822, 1996
-
(1996)
Cancer Res
, vol.56
, pp. 2815-2822
-
-
Eccles, S.A.1
Box, G.M.2
Court, W.J.3
Bone, E.A.4
Thomas, W.5
Brown, P.D.6
-
35
-
-
0028889359
-
Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice
-
Sledge GW, Qulali M, Goulet R, Bone EA, Fife R: Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Res 87: 1546-1550, 1995
-
(1995)
J Natl Cancer Res
, vol.87
, pp. 1546-1550
-
-
Sledge, G.W.1
Qulali, M.2
Goulet, R.3
Bone, E.A.4
Fife, R.5
-
36
-
-
0028625431
-
Low molecular weight inhibitors in corneal ulceration
-
Galardy RE, Cassabone ME, Giese C, Gilbert JH, Lapierre F, Lopez H, Scaefer ME, Stack R, Sullivan M, Summers B, Tressler R, Tyrrell D, Wee J, Allen SD, Castellot JJ, Barletta JP, Schultz G, Fernandez LA, Fisher S, Cui T-Y, Foellmer HG, Grobelny D, Holleran WM: Low molecular weight inhibitors in corneal ulceration. Ann NY Acad Sci 732:315-323, 1994
-
(1994)
Ann NY Acad Sci
, vol.732
, pp. 315-323
-
-
Galardy, R.E.1
Cassabone, M.E.2
Giese, C.3
Gilbert, J.H.4
Lapierre, F.5
Lopez, H.6
Scaefer, M.E.7
Stack, R.8
Sullivan, M.9
Summers, B.10
Tressler, R.11
Tyrrell, D.12
Wee, J.13
Allen, S.D.14
Castellot, J.J.15
Barletta, J.P.16
Schultz, G.17
Fernandez, L.A.18
Fisher, S.19
Cui, T.-Y.20
Foellmer, H.G.21
Grobelny, D.22
Holleran, W.M.23
more..
-
37
-
-
0002244576
-
Phase I study of matrix metalloproteinase (MMP) inhibitor batimastat (BB-94) in patients with malignant pleural effusions
-
Macaulay VM, O'Byrne KJ, Saunders MP, Salisbury A, Long L, Gleeson F, Ganesan TS, Harris AL, Talbot DC: Phase I study of matrix metalloproteinase (MMP) inhibitor batimastat (BB-94) in patients with malignant pleural effusions. Br J Cancer 71:11, 1995
-
(1995)
Br J Cancer
, vol.71
, pp. 11
-
-
Macaulay, V.M.1
O'Byrne, K.J.2
Saunders, M.P.3
Salisbury, A.4
Long, L.5
Gleeson, F.6
Ganesan, T.S.7
Harris, A.L.8
Talbot, D.C.9
-
38
-
-
0029847630
-
Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer
-
Wojtowicz-Praga S, Low J, Marshall J, Ness E, Dickson R, Barter J, Sale M, McCann, P, Moore J, Cole A, Hawkins MJ: Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer. Invest New Drugs 14:193-202, 1996
-
(1996)
Invest New Drugs
, vol.14
, pp. 193-202
-
-
Wojtowicz-Praga, S.1
Low, J.2
Marshall, J.3
Ness, E.4
Dickson, R.5
Barter, J.6
Sale, M.7
McCann, P.8
Moore, J.9
Cole, A.10
Hawkins, M.J.11
-
39
-
-
0026085334
-
Double-blind, placebo-controlled study of the three month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis
-
Lauhio A, Leirisalo-Repo M, Lahdevirta J, Saikku P, Repo H: Double-blind, placebo-controlled study of the three month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 24:6-14, 1991
-
(1991)
Arthritis Rheum
, vol.24
, pp. 6-14
-
-
Lauhio, A.1
Leirisalo-Repo, M.2
Lahdevirta, J.3
Saikku, P.4
Repo, H.5
-
40
-
-
0028631107
-
Low dose doxycycline inhibits pyridinoline excretion in selected patients with rheumatoid arthritis
-
Greenwald RA, Moak SA, Golub LM: Low dose doxycycline inhibits pyridinoline excretion in selected patients with rheumatoid arthritis. Ann NY Acad Sci 732:419-421, 1994
-
(1994)
Ann NY Acad Sci
, vol.732
, pp. 419-421
-
-
Greenwald, R.A.1
Moak, S.A.2
Golub, L.M.3
-
41
-
-
0345661206
-
Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers
-
in press
-
Millar AW, Brown PD, Moore J, Galloway WA, Cornish AG, Lenehan TJ, Lynch KP: Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers. Br J Clin Pharm, in press
-
Br J Clin Pharm
-
-
Millar, A.W.1
Brown, P.D.2
Moore, J.3
Galloway, W.A.4
Cornish, A.G.5
Lenehan, T.J.6
Lynch, K.P.7
-
42
-
-
0019835719
-
CEA (carcinoembryonic antigen): Its role as a marker in the management of cancer
-
Goldenberg DM, Neville A, Carter A: CEA (carcinoembryonic antigen): Its role as a marker in the management of cancer. J Cancer Res Clin Oncol 101:239-242, 1981
-
(1981)
J Cancer Res Clin Oncol
, vol.101
, pp. 239-242
-
-
Goldenberg, D.M.1
Neville, A.2
Carter, A.3
-
43
-
-
0022625713
-
Comparison of the sensitivity and specificity of the CA 19-9 and CEA assays in detecting cancer of the pancreas
-
Steinberg W, Gelfand R, Anderson K: Comparison of the sensitivity and specificity of the CA 19-9 and CEA assays in detecting cancer of the pancreas. Gastroenterology 90:343-349, 1986
-
(1986)
Gastroenterology
, vol.90
, pp. 343-349
-
-
Steinberg, W.1
Gelfand, R.2
Anderson, K.3
-
44
-
-
0024518775
-
CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer
-
Rubin SC, Hoskins WJ, Hakes TB: CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer. Am J Obstet Gynecol 160:667-671, 1989
-
(1989)
Am J Obstet Gynecol
, vol.160
, pp. 667-671
-
-
Rubin, S.C.1
Hoskins, W.J.2
Hakes, T.B.3
-
45
-
-
0024599612
-
Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients
-
Starney TA, Kabalin JW, McNeal JE: Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 141:1076-1083, 1989
-
(1989)
J Urol
, vol.141
, pp. 1076-1083
-
-
Starney, T.A.1
Kabalin, J.W.2
McNeal, J.E.3
-
46
-
-
0000003860
-
360 Patient meta-analysis of studies of marimastat, a novel matrix metalloproteinase inhibitor
-
Millar A, Brown P: 360 patient meta-analysis of studies of marimastat, a novel matrix metalloproteinase inhibitor. Ann Oncol 7:123, 1996
-
(1996)
Ann Oncol
, vol.7
, pp. 123
-
-
Millar, A.1
Brown, P.2
-
47
-
-
0002750508
-
A dose-finding study of marimastat, an oral matrix metalloproteinase inhibitor, in patients with advanced ovarian cancer
-
Poole C, Adams M, Barley V, Graham J, Kerr D, Louviaux I, Perren T, Piccart M, Thomas H: A dose-finding study of marimastat, an oral matrix metalloproteinase inhibitor, in patients with advanced ovarian cancer. Ann Oncol 7:68, 1996
-
(1996)
Ann Oncol
, vol.7
, pp. 68
-
-
Poole, C.1
Adams, M.2
Barley, V.3
Graham, J.4
Kerr, D.5
Louviaux, I.6
Perren, T.7
Piccart, M.8
Thomas, H.9
-
48
-
-
0001176281
-
A dose-finding study of marimastat, an oral matrix metalloproteinase inhibitor, in patients with advanced colorectal cancer
-
Primrose J, Bleiberg H, Daniel F, Johnson P, Mansi J, Neoptolemos J, Seymour M, Van Belle S: A dose-finding study of marimastat, an oral matrix metalloproteinase inhibitor, in patients with advanced colorectal cancer. Ann Oncol 7:35, 1996
-
(1996)
Ann Oncol
, vol.7
, pp. 35
-
-
Primrose, J.1
Bleiberg, H.2
Daniel, F.3
Johnson, P.4
Mansi, J.5
Neoptolemos, J.6
Seymour, M.7
Van Belle, S.8
-
49
-
-
0002635973
-
An open phase I/II study of the oral matrix metalloproteinase inhibitor marimastat in patients with inoperable gastric cancer
-
Parsons SL, Watson SA, Griffin NR, Steele RJC: An open phase I/II study of the oral matrix metalloproteinase inhibitor marimastat in patients with inoperable gastric cancer. Ann Oncol 7:47, 1996
-
(1996)
Ann Oncol
, vol.7
, pp. 47
-
-
Parsons, S.L.1
Watson, S.A.2
Griffin, N.R.3
Steele, R.J.C.4
-
50
-
-
0343900695
-
A phase I clinical trial of the MMP inhibitor, marimastat, administered concurrently with carboplatin to patients with relapsed ovarian cancer
-
Thomas H, Adams M: A phase I clinical trial of the MMP inhibitor, marimastat, administered concurrently with carboplatin to patients with relapsed ovarian cancer. Eur J Cancer 33:S246, 1997
-
(1997)
Eur J Cancer
, vol.33
-
-
Thomas, H.1
Adams, M.2
-
51
-
-
0030042145
-
Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma
-
Anderson IC, Shipp MA, Docherty AJP, Teicher BA: Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res 56:715-718, 1996
-
(1996)
Cancer Res
, vol.56
, pp. 715-718
-
-
Anderson, I.C.1
Shipp, M.A.2
Docherty, A.J.P.3
Teicher, B.A.4
-
52
-
-
0026440080
-
Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients
-
Foekens JA, Schmitt M, van Putten WLJ, Peters HA, Bontenbal M, Janicke F, Klijn JGM: Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res 52:6101-6105, 1992
-
(1992)
Cancer Res
, vol.52
, pp. 6101-6105
-
-
Foekens, J.A.1
Schmitt, M.2
Van Putten, W.L.J.3
Peters, H.A.4
Bontenbal, M.5
Janicke, F.6
Klijn, J.G.M.7
-
53
-
-
0028048915
-
Plasminogen activator inhibitor-1 and prognosis in primary breast cancer
-
Foekens JA, Schmitt M, van Putten WLJ, Peters HA, Kramer MD, Janicke F, Kiljn JGM: Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. J Clin Oncol 12:1648-1658, 1994
-
(1994)
J Clin Oncol
, vol.12
, pp. 1648-1658
-
-
Foekens, J.A.1
Schmitt, M.2
Van Putten, W.L.J.3
Peters, H.A.4
Kramer, M.D.5
Janicke, F.6
Kiljn, J.G.M.7
-
54
-
-
0015187844
-
The relative significance of prognostic factors in breast carcinoma
-
Alderson MR, Hamlin I, Staunton MD: The relative significance of prognostic factors in breast carcinoma. Br J Cancer 25:646-656, 1971
-
(1971)
Br J Cancer
, vol.25
, pp. 646-656
-
-
Alderson, M.R.1
Hamlin, I.2
Staunton, M.D.3
-
56
-
-
0016378540
-
Fibrosis as an indication of time in infiltrating breast cancer and its importance in prognosis
-
Anastassiades OT, Pryce PM: Fibrosis as an indication of time in infiltrating breast cancer and its importance in prognosis. Br J Cancer 29:232-239, 1974
-
(1974)
Br J Cancer
, vol.29
, pp. 232-239
-
-
Anastassiades, O.T.1
Pryce, P.M.2
-
57
-
-
0026648071
-
Simplified method of grading primary carcinomas of the breast
-
Parham DM, Hagen N, Brown RA: Simplified method of grading primary carcinomas of the breast. J Clin Pathol 45:517-520, 1992
-
(1992)
J Clin Pathol
, vol.45
, pp. 517-520
-
-
Parham, D.M.1
Hagen, N.2
Brown, R.A.3
-
58
-
-
0029050638
-
Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer
-
Carlomagno C, Perrone F, Lauria R, De Laurentiis M, Gallo C, Morabito A, Pettinato G, Panico L, Bellelli T, Apicella A, Petrella G, Bianco A, De Placido S: Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer. Oncology 52: 272-277, 1995
-
(1995)
Oncology
, vol.52
, pp. 272-277
-
-
Carlomagno, C.1
Perrone, F.2
Lauria, R.3
De Laurentiis, M.4
Gallo, C.5
Morabito, A.6
Pettinato, G.7
Panico, L.8
Bellelli, T.9
Apicella, A.10
Petrella, G.11
Bianco, A.12
De Placido, S.13
-
59
-
-
0028959485
-
Immunohistochemical fibronectin staining pattern and prognosis in invasive breast carcinoma
-
Takei H, Iino Y, Horiguchi J, Yakoe T: Immunohistochemical fibronectin staining pattern and prognosis in invasive breast carcinoma. Oncology 52:106-111, 1995
-
(1995)
Oncology
, vol.52
, pp. 106-111
-
-
Takei, H.1
Iino, Y.2
Horiguchi, J.3
Yakoe, T.4
|